Cargando…

Pathway-Based Integrative Analysis of Metabolome and Microbiome Data from Hepatocellular Carcinoma and Liver Cirrhosis Patients

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is one of the diseases associated with human microbiome. The human microbiome is known to affect human disease through the metabolites. The aim of this study was to identify the pathways associated with HCC by integrating microbiome and metabolomic data...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Boram, Cho, Eun Ju, Yoon, Jung-Hwan, Kim, Soon Sun, Cheong, Jae Youn, Cho, Sung Won, Park, Taesung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563418/ https://www.ncbi.nlm.nih.gov/pubmed/32967314 http://dx.doi.org/10.3390/cancers12092705

Ejemplares similares

Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from Cirrhosis
por: Kim, Da Jung, et al.
Publicado: (2019)

Circulating Microbiota-Based Metagenomic Signature for Detection of Hepatocellular Carcinoma
por: Cho, Eun Ju, et al.
Publicado: (2019)

Changes in serum fibronectin levels predict tumor recurrence in patients with early hepatocellular carcinoma after curative treatment
por: Kim, Sun Ah, et al.
Publicado: (2020)

Adding MRI as a Surveillance Test for Hepatocellular Carcinoma in Patients with Liver Cirrhosis Can Improve Prognosis
por: Yu, Su Jong, et al.
Publicado: (2023)

Risk of Liver Cirrhosis and Hepatocellular Carcinoma after Fontan Operation: A Need for Surveillance
por: Yoon, Jun Sik, et al.
Publicado: (2020)

The Risk Factors for Bleeding of Fundal Varices in Patients with Liver Cirrhosis
por: Park, Eui Ju, et al.
Publicado: (2013)

Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma
por: Kwon, Soon Ha, et al.
Publicado: (2012)

The Change in Metabolic Syndrome Status and the Risk of Nonviral Liver Cirrhosis
por: Chung, Goh-Eun, et al.
Publicado: (2021)

Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression
por: He, Michelle Junyi, et al.
Publicado: (2022)

Bioelectrical impedance analysis for predicting postoperative complications and survival after liver resection for hepatocellular carcinoma
por: Lee, Gil Ho, et al.
Publicado: (2021)

Prediction of compensated liver cirrhosis by ultrasonography and routine blood tests in patients with chronic viral hepatitis
por: Lee, Hong Sub, et al.
Publicado: (2010)

Profiling of Exome Mutations Associated with Progression of HBV-Related Hepatocellular Carcinoma
por: Woo, Hyun Goo, et al.
Publicado: (2014)

Revision and update on clinical practice guideline for liver cirrhosis
por: Suk, Ki Tae, et al.
Publicado: (2012)

Ultrasound-guided percutaneous portal transplantation of peripheral blood monocytes in patients with liver cirrhosis
por: Yu, Su Jong, et al.
Publicado: (2017)

Association of Polymorphism in MicroRNA 604 with Susceptibility to Persistent Hepatitis B Virus Infection and Development of Hepatocellular Carcinoma
por: Cheong, Jae Youn, et al.
Publicado: (2014)

Metronidazole-induced encephalopathy in a patient with liver cirrhosis
por: Cheong, Hyeong Cheol, et al.
Publicado: (2011)

Factor analysis of the biochemical markers related to liver cirrhosis
por: Kim, Hyun-Jin, et al.
Publicado: (2015)

Infiltrative hepatocellular carcinoma with multiple lung metastasis completely cured using nivolumab: a case report
por: Han, Ji Eun, et al.
Publicado: (2021)

Risk Prediction Model Based on Magnetic Resonance Elastography-Assessed Liver Stiffness for Predicting Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma
por: Cho, Hyo Jung, et al.
Publicado: (2022)

Serum Exosomal MicroRNA, miR-10b-5p, as a Potential Diagnostic Biomarker for Early-Stage Hepatocellular Carcinoma
por: Cho, Hyo Jung, et al.
Publicado: (2020)

Current Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B
por: Kim, Soon Sun, et al.
Publicado: (2011)

Liver transplantation in an adult patient with hepatocellular carcinoma following liver cirrhosis as a complication of the Fontan procedure -A case report-
por: Cho, Min-kyung, et al.
Publicado: (2020)

Association of Polymorphism in Pri-microRNAs-371-372-373 with the Occurrence of Hepatocellular Carcinoma in Hepatitis B Virus Infected Patients
por: Kwak, Min-Sun, et al.
Publicado: (2012)

Gut Microbiome and Metabolome Profiles Associated with High-Fat Diet in Mice
por: Jo, Jae-Kwon, et al.
Publicado: (2021)

Circulating Exosomal MicroRNA-1307-5p as a Predictor for Metastasis in Patients with Hepatocellular Carcinoma
por: Eun, Jung Woo, et al.
Publicado: (2020)

Barcelona clinic liver cancer-stage C hepatocellular carcinoma: A novel approach to subclassification and treatment
por: Jun, Chung Hwan, et al.
Publicado: (2017)

Novel Gene Signatures as Prognostic Biomarkers for Predicting the Recurrence of Hepatocellular Carcinoma
por: Son, Ju A, et al.
Publicado: (2022)

Hypomethylation-mediated upregulation of the WASF2 promoter region correlates with poor clinical outcomes in hepatocellular carcinoma
por: Ahn, Hye Ri, et al.
Publicado: (2022)

Effect of direct-acting antivirals for hepatitis C virus-related hepatocellular carcinoma recurrence and death after curative treatment
por: Ahn, Young-Hwan, et al.
Publicado: (2022)

Tumor Endothelial Cells-Associated Integrin Alpha-6 as a Promising Biomarker for Early Detection and Prognosis of Hepatocellular Carcinoma
por: Kim, Hyung Seok, et al.
Publicado: (2023)

Exosomal microRNA‐4661‐5p–based serum panel as a potential diagnostic biomarker for early‐stage hepatocellular carcinoma
por: Cho, Hyo Jung, et al.
Publicado: (2020)

Clinical Implications of the Serum Apelin Level on Portal Hypertension and Prognosis of Liver Cirrhosis
por: Lim, Yoo Li, et al.
Publicado: (2016)

Early detection of hepatocellular carcinoma via liquid biopsy: panel of small extracellular vesicle‐derived long noncoding RNAs identified as markers
por: Kim, Soon Sun, et al.
Publicado: (2021)

Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B
por: Cho, Hyo Jung, et al.
Publicado: (2014)

Aberrantly Expressed MicroRNAs in Cancer-Associated Fibroblasts and Their Target Oncogenic Signatures in Hepatocellular Carcinoma
por: Eun, Jung Woo, et al.
Publicado: (2023)

Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction
por: Kim, Da Jung, et al.
Publicado: (2018)

MLH1 single-nucleotide variant in circulating tumor DNA predicts overall survival of patients with hepatocellular carcinoma
por: Kim, Soon Sun, et al.
Publicado: (2020)

Usefulness of ascitic fluid lactoferrin levels in patients with liver cirrhosis
por: Lee, Sang Soo, et al.
Publicado: (2016)

Evaluation of Low-Molecular-Weight Heparin for Treatment of Portal Vein Thrombosis in Liver Cirrhosis Patients
por: Han, Ji Min, et al.
Publicado: (2023)

Profiling of plasma metabolomics in patients with hepatitis C-related liver cirrhosis and hepatocellular carcinoma
por: Nomair, Azhar Mohamed, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ts1thuhg9pf36pal927q2quk9j